MoonLake Immunotherapeutics Class A MLTX 深 沪
等待开盘 04-01 09:30:00 美东时间
18.64
+1.710
+10.10%
华盛通- 最 高19.00
- 今 开17.24
- 成交量 301.47万股
- 最 低 17.2152
- 昨 收 16.93
- 总市值 13.40亿
- 52周最高 62.75
- 市盈率 静 --
- 换手率 4.19%
- 52周最低 5.95
- 委 比 64.97%
- 总股本 7189.98万
- 历史最高 64.98
- 量 比 3.40
- 振 幅 10.54%
- 历史最低 4.25
- 每 手 1
- 风险率 17.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
MoonLake Says Lead Drug Shows Durable Response, Eyes FDA Filing
MoonLake shares fluctuate as Phase 3 HS data show 62% HiSCR75 response at Week 40; FDA feedback supports potential path without new trials.
03-30 23:27
BTIG Reiterates Buy on MoonLake, Maintains $30 Price Target
BTIG analyst Julian Harrison reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $30 price target.
03-30 20:43
美股大行评级 | 瑞穗上调MongoDB至"跑赢大市"，目标价从290美元升至325美元；麦格理下调小鹏评级至"中性" 目标价从24美元降至19美元
今日重点评级关注：HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从12美元升至13美元；Litchfield Hills：维持Star Equity Holdings"买入"评级，目标价从21美元升至28美元
03-24 10:07
This APA Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Monday
Top Wall Street analysts upgraded APA Corp. & MoonLake Immunotherapeutics, see why & what other analysts think on our analyst ratings page.
03-23 23:22
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
Rothschild & Co Upgrades MoonLake to Buy, Raises Price Target to $40
Rothschild & Co analyst Qize Ding upgrades MoonLake (NASDAQ:MLTX) from Neutral to Buy and raises the price target from $12 to $40.
03-20 01:26
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Uniqure To Rally Around 92%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page.
03-11 20:19
Clear Street Maintains Buy on MoonLake, Raises Price Target to $70
Clear Street analyst Kaveri Pohlman maintains MoonLake (NASDAQ:MLTX) with a Buy and raises the price target from $45 to $70.
03-11 19:15
